Valuation : Ovation Science Inc.

Market Cap 769K 554K 478K 452K 410K 52.95M 773K 5.37M 2.06M 26.94M 2.08M 2.04M 85.12M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 980K 706K 608K 576K 522K 67.46M 985K 6.84M 2.63M 34.32M 2.65M 2.59M 108M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 554K
+1.14%-1.05%-1.04%-6.71% 235B
+0.81%-2.33%+6.13% - 44.29B
+3.05%-5.58%+62.09% - 10.39B
+2.22%-1.19%+44.97%-39.75% 8.86B
+1.44%-1.95%+17.18%+7.99% 6.47B
+1.20%-11.63%-29.81%-28.45% 5.72B
+1.38%-4.01%+3.21%-14.39% 3.59B
-2.17%-9.25%-30.48%-46.91% 3.34B
+2.02%+0.93%+2.11%-32.38% 2.88B
Average -6.86%-3.31%+8.26%-22.94% 35.58B
Weighted average by Cap. +1.17%-1.55%+2.89%-8.81%

Financials

2024 2025
Net sales 113K 81.61K 70.32K 66.58K 60.35K 7.8M 114K 791K 304K 3.97M 306K 300K 12.53M 67.89K 48.94K 42.16K 39.92K 36.19K 4.68M 68.23K 474K 182K 2.38M 184K 180K 7.52M
Net income -456K -329K -283K -268K -243K -31.42M -459K -3.19M -1.23M -15.98M -1.24M -1.21M -50.51M -631K -455K -392K -371K -336K -43.47M -634K -4.41M -1.7M -22.12M -1.71M -1.67M -69.89M
Net Debt 265K 191K 165K 156K 141K 18.26M 267K 1.85M 712K 9.29M 718K 702K 29.36M 211K 152K 131K 124K 112K 14.51M 212K 1.47M 566K 7.38M 571K 558K 23.33M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!